These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 158700)

  • 1. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of involuntary movement disorders with tetrabenazine.
    Swash M; Roberts AH; Zakko H; Heathfield KW
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):186-91. PubMed ID: 4260957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS; Wodak J; Veale JL; Munro OR
    Med J Aust; 1972 Nov; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract]   [Full Text] [Related]  

  • 6. The suppression of involuntary movements with tetrabenazine.
    McLellan DL
    Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes.
    Fog R; Pakkenberg H
    Acta Neurol Scand; 1970; 46(2):249-51. PubMed ID: 4246984
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of tetrabenazine in hyperkinetic movement disorders.
    Jankovic J; Beach J
    Neurology; 1997 Feb; 48(2):358-62. PubMed ID: 9040721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Treatment of Huntington's chorea with tetrabenazine.
    Snaith RP; Warren HD
    Lancet; 1974 Mar; 1(7854):413-4. PubMed ID: 4131061
    [No Abstract]   [Full Text] [Related]  

  • 15. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tetrabenazine on extrapyramidal movement disorders.
    Dalby MA
    Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine (Xenazine) for Huntington's chorea.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE; Marsden CD
    Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic use of tetrabenazine].
    López Del Val LJ; López-García E; Martínez-Martínez L; Santos-Lasaosa S
    Rev Neurol; 2009 May 16-31; 48(10):523-33. PubMed ID: 19434587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.